華魯恆升(600426.SH):擬投資建設高端溶劑項目
格隆匯4月29日丨華魯恆升(600426.SH)公佈,2022年4月28日,公司以通訊方式召開了第八屆董事會第五次會議,審議通過了《關於投資建設高端溶劑項目的議案》。
項目以現有裝置生產的產品為主要原料,利用自主研發技術,建設兩套生產規模30萬噸/年的碳酸二甲酯裝置(其中一套為原有的碳酸二甲酯工業化試驗裝置);一套生產規模30萬噸/年的碳酸甲乙酯裝置;其他配套裝置、公用工程及輔助生產設施。
根據可行性研究報吿測算,該項目預計總投資10.31億元;項目建設資金由公司自有資金和銀行貸款解決;建設期20個月。
項目建成投產後,可年產碳酸二甲酯60萬噸(其中銷售量30萬噸)、碳酸甲乙酯30萬噸、碳酸二乙酯5萬噸。預計年均可實現營業收入45.45億元,利潤7.01億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.